Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.

Mylvaganam, Ruben J; Bailey, Joseph I; Sznajder, Jacob I; Sala, Marc A

Mylvaganam, Ruben J; Bailey, Joseph I; Sznajder, Jacob I; Sala, Marc A.

Afiliación

Mylvaganam RJ; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA ruben.mylvaganam@northwestern.edu.
Bailey JI; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Sznajder JI; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Sala MA; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Eur Respir Rev ; 30(162)2021 Dec 31.

Article en En | MEDLINE | ID: mdl-34911696

Asunto(s)

COVID-19; Fibrosis Pulmonar; Humanos; Pandemias; Estudios Prospectivos; Fibrosis Pulmonar/diagnóstico; Fibrosis Pulmonar/epidemiología; Calidad de Vida; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Asunto principal: Fibrosis Pulmonar / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur Respir Rev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google